scispace - formally typeset
W

Wangyan Zhou

Researcher at University of South China

Publications -  5
Citations -  14

Wangyan Zhou is an academic researcher from University of South China. The author has contributed to research in topics: Medicine & Cancer research. The author has an hindex of 1, co-authored 1 publications receiving 5 citations.

Papers
More filters
Journal ArticleDOI

Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1

TL;DR: It was posited that let-7c-5p/ESPL1 may be underlying therapeutic targets of LUAD, which was associated with poor prognosis and downregulated in LUAD cells, and played a suppressive role inLUAD malignant development while reversed by ESPL1.
Journal ArticleDOI

Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments

TL;DR: A CDK1-related ceRNA network was constructed and revealed the LINC00460/LINC00525-hsa-mir-338-FAM111/ZWINT pathways as potential diagnostic biomarkers or therapeutic targets of LUAD.
Journal ArticleDOI

Identification of EGFR-Related LINC00460/mir-338-3p/MCM4 Regulatory Axis as Diagnostic and Prognostic Biomarker of Lung Adenocarcinoma Based on Comprehensive Bioinformatics Analysis and Experimental Validation

TL;DR: The LINC00460—mir-338-3p—MCM4 ceRNA network plays an important role in the diagnosis and prognosis of LUAD and is expected to serve as a diagnostic, prognostic and drug target for LUAD.
Journal ArticleDOI

Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset

TL;DR: The study indicated that securin overexpression was positively associated with metastasis and inversely related to the prognosis of patients with solid cancers, however, additional high-quality studies should be conducted to validate these findings.